Scientists identify nearly a dozen genes responsible for coronary artery calcification

This week, Stealth Bio­Ther­a­peu­tics CEO Ree­nie Mc­Carthy faced a seem­ing­ly in­sur­mount­able road­block with the com­pa­ny’s drug for the ul­tra-rare, fa­tal mi­to­chon­dr­i­al dis­ease Barth syn­drome. FDA

A new start­up aim­ing to tack­le rare dis­eases de-stealthed Wednes­day morn­ing with a CEO ex­pe­ri­enced in the space. Ales­ta Ther­a­peu­tics took the wraps off its